Mateos, M.-V., Weisel, K., Martin, T., Berdeja, J. G., Jakubowiak, A., Stewart, A. K., Jagannath, S., Lin, Y., Diels, J., Ghilotti, F., Thilakarathne, P., Perualila, N. J., Cabrieto, J., Haefliger, B., Erler-Yates, N., Hague, C., Jackson, C. C., Schecter, J. M., Strulev, V., Nesheiwat, T., Pacaud, L., Einsele, H. and Moreau, P. (2023) “Adjusted comparison of outcomes between patients from CARTITUDE-1 <i>versus</i&gt; multiple myeloma patients with prior exposure to proteasome inhibitors, immunomodulatory drugs and anti-CD38 antibody from the prospective, multinational LocoMMotion study of real-world clinical practice”, Haematologica. Pavia, Italy, 108(8), pp. 2192-2204. doi: 10.3324/haematol.2022.280482.